Research laboratories seeking to analyze Vilon dipeptide (Lys-Glu) in enzymatic and gene expression assays require verified, analytical-grade material. PX1 Research supplies high-purity Vilon synthesized in USA-based facilities, complete with lot-specific third-party COAs including RP-HPLC and mass spectrometry verification. Designed strictly for in vitro and preclinical investigation, our research compounds meet rigorous quality parameters for experimental reproducibility.
Research laboratories seeking to analyze Vilon dipeptide (Lys-Glu) in enzymatic and gene expression assays require verified, analytical-grade material. PX1 Research supplies high-purity Vilon synthesized in USA-based facilities, complete with lot-specific third-party COAs including RP-HPLC and mass spectrometry verification. Designed strictly for in vitro and preclinical investigation, our research compounds meet rigorous quality parameters for experimental reproducibility.
Researchers looking to buy Vilon to evaluate its influence on enzyme activity require high-purity, analytical-grade Lys-Glu dipeptide with documented chemical identity and freedom from endotoxins. PX1 Research provides USA-manufactured Vilon backed by lot-specific third-party HPLC/MS certificates of analysis, ensuring reliable, reproducible experimental results across enzymatic and chromatin-modulating assays.
When designing protocols to investigate how short peptides modulate intracellular enzymatic cascades, batch-to-batch consistency is paramount. Impurities, residual synthesis solvents, or improper salt forms can introduce confounding variables in spectrophotometric or fluorometric assays. Obtaining fully characterized Vilon dipeptide ensures that observed shifts in enzyme kinetics, such as superoxide dismutase upregulation or chromatin remodeling activity, stem entirely from the active peptide sequence rather than exogenous contaminants.
Vilon is a synthetic peptide bioregulator consisting of two amino acid residues: L-lysine and L-glutamic acid (Lys-Glu or KE). Despite its small molecular weight (275.3 g/mol), this short chain possesses high biological specificity in cell culture and cell-free assay environments. The terminal amino and carboxyl groups, combined with the charged side chains of lysine and glutamic acid, allow the dipeptide to interact with polar regions of nucleic acids and protein complexes.
In biochemical investigations, the structural simplicity of Lys-Glu facilitates precise computational modeling of peptide-DNA and peptide-protein binding kinetics. Researchers examining the broad library of bioregulatory short peptides frequently utilize Vilon as a baseline model for analyzing how ultra-short sequences enter the cell nucleus to interact with histones and enzyme promoters without requiring specialized transport vehicles.
Preclinical studies indicate that Vilon influences cellular metabolism primarily through epigenetic modulation and direct or indirect enzyme activation. In vitro assays demonstrate that short regulatory peptides can bind to specific sequence motifs in DNA, altering chromatin condensation and enhancing accessibility for RNA polymerase II and associated transcriptional enzymes.
Among the primary enzyme systems investigated in relation to Vilon are endogenous antioxidant enzymes. In vitro data suggest that exposure to Lys-Glu dipeptides correlates with increased activity of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) in primary cell cultures under oxidative stress conditions. By modulating the gene expression of these enzymatic defense systems, Vilon serves as an important tool for investigating cellular resistance to reactive oxygen species (ROS).
Additionally, preclinical models evaluating chromatin dynamics show that Vilon may influence histone acetyltransferase (HAT) and histone deacetylase (HDAC) activity. By shifting the balance of histone acetylation, the peptide facilitates local decondensation of heterochromatin, thereby reactivating silenced gene loci associated with cellular maintenance and immune signaling.
In vitro and animal model studies have evaluated Vilon across diverse research paradigms, particularly involving thymic epithelial cells, lymphocytes, and fibroblast cultures. In rodent models of accelerated cellular aging, administration of Lys-Glu was observed to restore thymic function, promote T-lymphocyte differentiation, and normalize the enzymatic profile of immunocompetent cells.
Laboratory investigations targeting immune cell signaling report that Vilon modulates the expression of key cytokines and membrane-bound enzymes. For example, in vitro assays involving primary splenocytes demonstrated restored activity of membrane ATPases and protein kinases following exposure to Lys-Glu under toxic stress conditions. Findings recorded in the PX1 research database highlight how these enzymatic adjustments contribute to preserved cellular viability and structural integrity in controlled stress protocols.
Understanding the selective activity of short peptides requires comparative evaluation alongside structurally related research compounds. Vilon (Lys-Glu) belongs to a class of synthetic peptide bioregulators originally derived from tissue extract analysis, each displaying targeted tissue tropism and unique enzymatic targets in preclinical literature.
When configuring broad-spectrum comparative assays, researchers frequently run Vilon alongside Epitalon (Ala-Glu-Asp-Gly), a tetrapeptide extensively studied for telomerase enzyme activation and pineal gland modulation, and Thymogen (Glu-Trp), another immune-focused dipeptide that targeting distinct T-cell maturation cascades. While Thymogen emphasizes cell-mediated immune responses, Vilon exhibits broader epigenetic activity across diverse connective and epithelial tissue lines. For tissue repair models, researchers may also contrast Vilon's enzymatic pathways with systemic repair compounds like BPC-157.
Vilon is supplied as a lyophilized (freeze-dried) powder to maximize chemical stability during transport and long-term storage. To preserve structural integrity and prevent enzymatic degradation prior to testing, strict laboratory reconstitution protocols must be followed.
For most cell culture and cell-free enzyme assays, lyophilized Vilon should be reconstituted using sterile, bacteriostatic water or standard phosphate-buffered saline (PBS, pH 7.4). The dipeptide exhibits excellent aqueous solubility due to its polar side chains. Reconstitution should be performed by gently swirling the vial; vigorous vortexing or mechanical agitation should be avoided to prevent protein shearing or foam formation. Once reconstituted, stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles, which can degrade peptide integrity over time. Stock aliquots should be stored at -20°C or -80°C.
Reliable scientific inquiry requires verified materials. When purchasing Vilon for enzyme activity assays, researchers must ensure the supplier provides lot-specific analytical verification rather than generic or batch-pooled certificates.
PX1 Research enforces strict quality control across every production lot, utilizing independent ISO 17025 accredited testing laboratories. Essential analytical techniques include:
• Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC): Establishes chemical purity by separating the primary target peptide from synthesis side products, ensuring a minimum purity standard of 98%.
• Liquid Chromatography-Mass Spectrometry (LC-MS): Confirms exact molecular weight and amino acid sequence identity, verifying the precise 275.3 g/mol structure of Lys-Glu.
• Bacterial Endotoxin Testing (LAL Assay): Measures lipopolysaccharide contamination to guarantee levels fall below strict threshold limits (<0.01 EU/mg), preventing non-specific inflammatory responses in sensitive cell culture models.
Researchers can browse our comprehensive peptide catalog to access downloadable Certificates of Analysis for every available compound.
Integrating Vilon into enzymatic research protocols requires careful control of assay conditions. Because short dipeptides can interact non-covalently with enzyme active sites or metal cofactors, investigators should establish baseline controls that isolate peptide-specific effects from buffer background signals.
Common detection methods include spectrophotometric absorbance assays (e.g., monitoring NADPH consumption in antioxidant enzyme assays), fluorometric kinetic assays for histone deacetylase activity, and RT-qPCR quantification of enzyme mRNA transcription levels post-incubation. Including negative controls (vehicle-only) and positive controls (known enzymatic activators or inhibitors) ensures that observed shifts in catalytic velocity ($V_{max}$) or binding affinity ($K_m$) are directly attributable to the presence of Vilon.
PX1 Research operates strictly as a domestic supply partner for academic institutions, biotechnology firms, and independent research facilities across the United States. All products are synthesized within GMP-compliant facilities and shipped directly from our primary distribution hubs in California and Arizona.
By maintaining strict chain-of-custody protocols and providing fully transparent third-party testing data, PX1 eliminates the risk of counterfeit compounds, heavy metal contamination, or peptide degradation common with unverified international vendors. Orders placed before daily cutoff deadlines ship same-day (Monday through Friday), ensuring rapid turnaround for time-sensitive cell culture schedules.
For high-throughput screening projects, longitudinal animal studies, or multi-departmental research initiatives, PX1 Research provides scalable procurement solutions. We support custom vial aliquoting, bulk mass options (gram-scale lyophilized powder), and streamlined purchase order processing for university and government laboratories.
Principal investigators and lab managers seeking sustained supply lines or specialized contract manufacturing can register through our wholesale research portal to access institutional pricing tiers and dedicated account management support.
What primary enzyme systems are investigated with Vilon in preclinical studies?
Preclinical literature focuses primarily on Vilon's influence over endogenous antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase), chromatin-modifying enzymes (histone acetyltransferases and deacetylases), and immune-related kinase cascades.
How does PX1 Research verify the purity of Vilon?
Every lot of Vilon undergoes independent third-party verification using Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity analysis (>98%) and Mass Spectrometry (LC-MS) for exact molecular weight and sequence identity confirmation.
Is Vilon endotoxin tested prior to dispatch?
Yes. PX1 Research conducts Limulus Amebocyte Lysate (LAL) testing on all research peptide lots to ensure bacterial endotoxin levels remain strictly below <0.01 EU/mg, preventing cell culture toxicity or spurious immune responses.
What is the recommended reconstitution solvent for Vilon in enzymatic assays?
For most in vitro enzyme assays, Vilon is reconstituted in sterile bacteriostatic water or standard phosphate-buffered saline (PBS, pH 7.4). The dipeptide exhibits high aqueous solubility due to its polar charged amino acids.
How should reconstituted Vilon stock solutions be stored?
Reconstituted stock solutions should be divided into single-use aliquots and stored at -20°C or -80°C to minimize freeze-thaw degradation. Lyophilized vials should be stored at -20°C prior to reconstitution.
What is the molecular weight and sequence of Vilon?
Vilon is a synthetic dipeptide composed of L-lysine and L-glutamic acid (Lys-Glu / KE) with a molecular formula of C11H21N3O5 and a molecular weight of 275.3 g/mol.
Can Vilon be ordered in bulk for high-throughput screening?
Yes. PX1 Research offers institutional procurement options, including custom mass aliquoting and gram-scale supply for qualified research laboratories via our wholesale account portal.
Where are PX1 Research compounds synthesized and shipped from?
All PX1 Research peptides are manufactured in USA-based, GMP-compliant facilities and dispatched directly from our distribution centers located in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.